My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exponent, Inc. - Common Stock (NQ:EXPO)

68.86 -0.02 (-0.03%)
Streaming Delayed Price Updated: 1:29 PM EDT, Sep 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exponent, Inc. - Common Stock

< Previous 1 2 3 4 Next >
1 Services Stock for Long-Term Investors and 2 That Underwhelm
Business services providers play a critical role for enterprises, assisting them with everything from new hardware integrations to consulting and marketing. Furthermore, the demand for their offerings... 
Via StockStory
Topics Stocks
3 Small-Cap Stocks That Fall Short
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
1 Oversold Stock Ready to Bounce Back and 2 We Brush Off
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
Winners And Losers Of Q2: Exponent (NASDAQ:EXPO) Vs The Rest Of The Business Process Outsourcing & Consulting Stocks
Let’s dig into the relative performance of Exponent (NASDAQ:EXPO) and its peers as we unravel the now-completed Q2 business process outsourcing & consulting earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Earnings Scheduled For May 1, 2025
 
Via Benzinga
2 Cash-Heavy Stocks Worth Investigating and 1 We Ignore
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
EXPO Q2 Deep Dive: Litigation Demand Offsets Flat Revenue, Margin Compression Persists
Scientific consulting firm Exponent (NASDAQ:EXPO) beat Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $132.9 million. On the other hand, next quarter’s revenue... 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks with Open Questions
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Exponent (EXPO) Q2 Revenue Rises 1%
Via The Motley Fool
Topics Artificial Intelligence Product Recall
CDW, CRA, Crane NXT, Diebold Nixdorf, and Exponent Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after a surprisingly weak U.S. jobs report was released, fueling concerns about a slowing economy. 
Via StockStory
Topics Artificial Intelligence Economy
Exponent’s (NASDAQ:EXPO) Q2: Beats On Revenue But Quarterly Revenue Guidance Slightly Misses Expectations
Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.2% year on year to $142 million. On the other hand, next... 
Via StockStory
Exponent Inc (NASDAQ:EXPO) Delivers Mixed Q2 2025 Results with EPS Beat and Revenue Miss, Market Reaction Neutral
Exponent Inc (NASDAQ:EXPO) reported mixed Q2 2025 results, with EPS beating estimates but revenue slightly missing. Shares remained flat post-earnings, reflecting neutral investor sentiment. The... 
Via Chartmill
Exponent Declares Regular Quarterly Dividend for Q3 2025
From Exponent, Inc.
Via GlobeNewswire
Exponent Reports Second Quarter 2025 Financial Results
From Exponent, Inc.
Via GlobeNewswire
Exponent Inc (NASDAQ:EXPO) Stands Out as a High-Quality Pick Under the Caviar Cruise Strategy
Exponent Inc (EXPO) excels with high profitability, strong cash flow, and steady growth, making it a top pick for long-term quality investors under the Caviar Cruise strategy. 
Via Chartmill
Exponent (EXPO) Reports Earnings Tomorrow: What To Expect
Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday afternoon. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
2 High-Flying Stocks to Target This Week and 1 to Avoid
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
Exponent to Announce Second Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on July 31, 2025
From Exponent, Inc.
Via GlobeNewswire
1 Small-Cap Stock with Competitive Advantages and 2 to Be Wary Of
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Business Process Outsourcing & Consulting Stocks Q1 Teardown: Exponent (NASDAQ:EXPO) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q1,... 
Via StockStory
Topics Artificial Intelligence Economy
3 Low-Volatility Stocks with Questionable Fundamentals
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
3 Out-of-Favor Stocks Skating on Thin Ice
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
EXPO Q1 Earnings Call: Resilient Results as Macro Uncertainty Impacts Guidance
Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $137.4 million. On the other hand, next quarter’s revenue... 
Via StockStory
3 High-Flying Stocks with Questionable Fundamentals
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
Exponent (NASDAQ:EXPO) Surprises With Q1 Sales But Quarterly Revenue Guidance Significantly Misses Expectations
Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q1 CY2025, with sales up 6% year on year to $145.5 million. On the other hand, next quarter’s revenue... 
Via StockStory
Exponent Reports First Quarter 2025 Financial Results
From Exponent, Inc.
Via GlobeNewswire
Exponent Declares Regular Quarterly Dividend for Q2 2025
From Exponent, Inc.
Via GlobeNewswire
Earnings To Watch: Exponent (EXPO) Reports Q1 Results Tomorrow
Scientific consulting firm Exponent (NASDAQ:EXPO) will be announcing earnings results tomorrow afternoon. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
3 Cash-Heavy Stocks Skating on Thin Ice
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.